Literature DB >> 30821631

Epidemiology of Macular Edema in Uveitis.

Massimo Accorinti1, Annabelle A Okada2, Justine R Smith3, Marta Gilardi4.   

Abstract

PURPOSE: To describe the epidemiology of macular edema (ME) in patients with uveitis.
METHODS: Review of articles listed on PubMed pertaining to uveitic ME.
RESULTS: Reported rates of uveitic ME ranging from 20% to 70%, depending on the ancillary tests used (fundus examination, fluorescein angiography, optical coherence tomography). Macular edema might develop due to uveitis itself, or occur as an adverse effect of drugs taken for different diseases. It is more frequently observed in adults than in children, in chronic uveitis, and in intermediate uveitis. Males with ankylosing spondylitis are more prone to develop ME than females. Three patterns of uveitic ME are observed, either isolated or in combination: cystoid ME, the most frequently encountered pattern seen in up to 80% of cases, diffuse ME and serous retinal detachment.
CONCLUSION: Older age, chronicity of uveitis and intermediate uveitis are risk factors for the development of ME in patients with uveitis.

Entities:  

Keywords:  Epidemiology; drug toxicity; macular edema; macular edema patterns; uveitis

Year:  2019        PMID: 30821631     DOI: 10.1080/09273948.2019.1576910

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  9 in total

1.  Increased vitreous levels of B cell activation factor (BAFF) and soluble interleukin-6 receptor in patients with macular edema due to uveitis related to Behçet's disease and sarcoidosis.

Authors:  Atsunobu Takeda; Eiichi Hasegawa; Nobuyo Yawata; Shoji Notomi; Keijiro Ishikawa; Yusuke Murakami; Toshio Hisatomi; Kazuhiro Kimura; Koh-Hei Sonoda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-01       Impact factor: 3.535

2.  Persistence of Juvenile Idiopathic Arthritis-Associated Uveitis in Adulthood: A Retrospective Study.

Authors:  Maria Pia Paroli; Alessandro Abbouda; Giuseppe Albanese; Massimo Accorinti; Alessandro Falcione; Leopoldo Spadea; Marino Paroli
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

Review 3.  Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence.

Authors:  Sajida Sabsabi; Elio Mikhael; Georges Jalkh; Gabrielle Macaron; Mary Rensel
Journal:  Patient Prefer Adherence       Date:  2022-05-24       Impact factor: 2.314

Review 4.  Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature.

Authors:  Claudio Iovino; Rodolfo Mastropasqua; Marco Lupidi; Daniela Bacherini; Marco Pellegrini; Federico Bernabei; Enrico Borrelli; Riccardo Sacconi; Adriano Carnevali; Rossella D'Aloisio; Alessio Cerquaglia; Lucia Finocchio; Andrea Govetto; Stefano Erba; Giacinto Triolo; Antonio Di Zazzo; Matteo Forlini; Aldo Vagge; Giuseppe Giannaccare
Journal:  Pharmaceutics       Date:  2020-07-26       Impact factor: 6.321

Review 5.  Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.

Authors:  Horace Massa; Spyros Y Pipis; Georgios D Panos; Temilade Adewoyin; Athanasios Vergados; Sudeshna Patra
Journal:  Clin Ophthalmol       Date:  2019-09-10

6.  Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer's perspective.

Authors:  Seenu M Hariprasad; George Joseph; Patrick Gagnon-Sanschagrin; Elizabeth Serra; Subrata Bhattacharyya; Jérôme Bédard; Annie Guérin; Thomas Arno Albini
Journal:  BMJ Open Ophthalmol       Date:  2021-11-10

7.  The Trend of Drug Therapy on Uveitic Macular Edema: A Bibliometric Analysis of the 100 Most Cited Articles.

Authors:  Si Chen; Jinfeng Kong; Lei Feng
Journal:  Front Med (Lausanne)       Date:  2022-02-23

8.  Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema.

Authors:  Dan Lin; Jiajiang Hu; Ke Wu; Kemi Feng; Xia Zhao; Qingqing Lu; Mingxue Ren; Junlin Cao; Ruru Liu; Mali Dai; Kaihui Nan; Yuqin Wang
Journal:  Drug Des Devel Ther       Date:  2022-04-08       Impact factor: 4.162

9.  Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study.

Authors:  Ruilin Zhu; Shiyu Xiao; Wenbo Zhang; Jun Li; Menglu Yang; Yadi Zhang; Xiaopeng Gu; Liu Yang
Journal:  BMC Ophthalmol       Date:  2022-08-29       Impact factor: 2.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.